Thrivent Financial for Lutherans’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-50,137
| Closed | -$1.6M | – | 2501 |
|
2022
Q2 | $1.6M | Sell |
50,137
-3,347
| -6% | -$107K | ﹤0.01% | 1376 |
|
2022
Q1 | $1.85M | Sell |
53,484
-55
| -0.1% | -$1.91K | ﹤0.01% | 1376 |
|
2021
Q4 | $1.57M | Buy |
53,539
+272
| +0.5% | +$7.96K | ﹤0.01% | 1562 |
|
2021
Q3 | $1.36M | Buy |
53,267
+329
| +0.6% | +$8.38K | ﹤0.01% | 1637 |
|
2021
Q2 | $1.85M | Buy |
52,938
+847
| +2% | +$29.7K | ﹤0.01% | 1464 |
|
2021
Q1 | $2.12M | Sell |
52,091
-85,437
| -62% | -$3.48M | ﹤0.01% | 1380 |
|
2020
Q4 | $5.96M | Buy |
137,528
+45,380
| +49% | +$1.97M | 0.01% | 801 |
|
2020
Q3 | $5.08M | Buy |
92,148
+78,037
| +553% | +$4.3M | 0.01% | 788 |
|
2020
Q2 | $890K | Hold |
14,111
| – | – | ﹤0.01% | 1572 |
|
2020
Q1 | $720K | Buy |
+14,111
| New | +$720K | ﹤0.01% | 1505 |
|
2017
Q2 | – | Sell |
-30,400
| Closed | -$1.12M | – | 2092 |
|
2017
Q1 | $1.12M | Sell |
30,400
-21,070
| -41% | -$776K | ﹤0.01% | 1102 |
|
2016
Q4 | $744K | Hold |
51,470
| – | – | ﹤0.01% | 1302 |
|
2016
Q3 | $1.19M | Hold |
51,470
| – | – | 0.01% | 1065 |
|
2016
Q2 | $854K | Buy |
+51,470
| New | +$854K | ﹤0.01% | 1170 |
|